Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021
Thu, December 16, 2021
Wed, December 15, 2021
Tue, December 14, 2021

Hartaj Singh Initiated (SPRB) at Buy and Held Target at $15 on, Dec 17th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-dec-17th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Hartaj Singh of Oppenheimer, Initiated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $15 on, Dec 17th, 2021.

Hartaj has made no other calls on SPRB in the last 4 months.



There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 2 agree with Hartaj's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Tuesday, November 23rd, 2021
  • Joseph Schwartz of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $5 on, Tuesday, November 16th, 2021


These are the ratings of the 3 analyists that currently disagree with Hartaj


  • Aydin Huseynov of "Benchmark" Initiated at Buy and Held Target at $7 on, Friday, December 10th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $6 on, Tuesday, November 16th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, November 16th, 2021

Publication Contributing Sources